San Diego, CA
Booth: XXX
With ready-to-use assays, custom models and high-throughput screening capabilities, Ncardia offers the precision and reproducibility needed to move neuroscience forward.
Join us at the Society for Neuroscience 2025 Annual Meeting for an inside look at our iPSC-based platforms — including dopaminergic neurons, motor neurons, microglia and neural mixes — and how they’re built for scalability, reproducibility and translational insight across neurodegenerative, neuroinflammatory and psychiatric disease areas.
Whether you’re advancing early-stage discovery, modeling disease mechanisms or improving CNS safety assessments, it’s time to accelerate your next breakthrough.
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.